Broad Biomarker Catalog A broad and growing biomarker menu across key therapeutic areas enables flexible multiplex assays for research, drug discovery, and diagnostic development.

Ultrasensitive Assays Ciraplex ULTRA ultrasensitive assays demonstrate the ability to detect low-abundance biomarkers, creating upsell opportunities for high-sensitivity workflows in pharma, biotech, and academic labs.

Multi-Segment Market Global pharma, biotech, academic, and diagnostic customers indicate a multi-segment addressable market with potential for cross-selling and bundled services, including assays, instrumentation, and data analysis.

Acquisition Context Acquisition by Quanterix suggests partnership or integration opportunities to access a larger customer base and complementary capabilities, enabling joint value propositions around multiplexing and microarray analysis.

Nimble Customer Focus A nimble mid-sized team can provide high-touch customer support and rapid iteration, offering channel partnerships or specialized service packages to accelerate adoption among research laboratories and CROs.